Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.
Sendra E, López Montesinos I, Rodriguez-Alarcón A, Du J, Siverio-Parés A, Arenas-Miras M, Cañas-Ruano E, Prim N, Durán-Jordà X, Blasco-Hernando F, García-Alzorriz E, Cots F, Ferrández O, Gómez-Zorrilla S. Sendra E, et al. Among authors: lopez montesinos i. Antibiotics (Basel). 2022 Oct 29;11(11):1511. doi: 10.3390/antibiotics11111511. Antibiotics (Basel). 2022. PMID: 36358167 Free PMC article.
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality.
de Pablo-Miró M, Pujol-Ruiz S, Iftimie S, Arenas-Miras MDM, López-Montesinos I, Duran-Jordà X, Anglès A, Grau S, Horcajada JP. de Pablo-Miró M, et al. Among authors: lopez montesinos i. Antibiotics (Basel). 2021 Oct 24;10(11):1296. doi: 10.3390/antibiotics10111296. Antibiotics (Basel). 2021. PMID: 34827234 Free PMC article.
Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study.
López Montesinos I, Gómez-Zorrilla S, Palacios-Baena ZR, Prim N, Echeverria-Esnal D, Gracia MP, Montero MM, Durán-Jordà X, Sendra E, Sorli L, Guerri-Fernandez R, Padilla E, Grau S, Horcajada JP; PROA PSMAR group. López Montesinos I, et al. Infect Dis Ther. 2022 Feb;11(1):335-350. doi: 10.1007/s40121-021-00570-z. Epub 2021 Dec 3. Infect Dis Ther. 2022. PMID: 34860333 Free PMC article.
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence.
Lopez-Montesinos I, Montero MM, Domene-Ochoa S, López-Causapé C, Echeverria D, Sorlí L, Campillo N, Luque S, Padilla E, Prim N, Grau S, Oliver A, Horcajada JP. Lopez-Montesinos I, et al. Antibiotics (Basel). 2022 Oct 22;11(11):1456. doi: 10.3390/antibiotics11111456. Antibiotics (Basel). 2022. PMID: 36358110 Free PMC article.
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Gómez-Zorrilla S, Becerra-Aparicio F, López Montesinos I, Ruiz de Gopegui E, Grau I, Pintado V, Padilla B, Benito N, Boix-Palop L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Durán-Jordá X, Díaz-Regañón J, López-Mendoza D, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP; REIPI/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group. Gómez-Zorrilla S, et al. Among authors: lopez montesinos i, lopez mendoza d. Infect Dis Ther. 2021 Dec;10(4):2677-2699. doi: 10.1007/s40121-021-00537-0. Epub 2021 Oct 9. Infect Dis Ther. 2021. PMID: 34626347 Free PMC article.
Comparison of Hospitalized Coronavirus Disease 2019 and Influenza Patients Requiring Supplemental Oxygen in a Cohort Study: Clinical Impact and Resource Consumption.
López Montesinos I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, Sorli L, Guerri-Fernández R, Arnau-Barrés I, Montero MM, Siverio-Parès A, Durán X, Del Mar Arenas M, Arnau AB, Cañas-Ruano E, Castañeda S, Kamber ID, Gómez-Junyent J, Pelegrín I, Martínez FS, Sendra E, Leiro LS, Villar-García J, Nogués X, Grau S, Knobel H, Gomez-Zorrilla S, Horcajada JP; COVID-MAR Group. López Montesinos I, et al. Clin Infect Dis. 2022 Dec 19;75(12):2225-2238. doi: 10.1093/cid/ciac314. Clin Infect Dis. 2022. PMID: 35442442 Free PMC article.
Antibiotic desensitization as a potential tool in antimicrobial stewardship programs: retrospective data analysis and systematic literature review.
Rodríguez-Alarcón A, Barceló-Vidal J, Echeverría-Esnal D, Sorli L, Güerri-Fernández R, Ramis Fernández SM, Benitez-Cano A, Sendra E, López Montesinos I, Membrilla-Fernández E, Ferrández O, Adalia R, Horcajada JP, Escolano F, Gómez-Zorrilla S, Grau S; , on behalf of PROA-PSMAR group.. Rodríguez-Alarcón A, et al. Among authors: lopez montesinos i. Expert Rev Anti Infect Ther. 2022 Nov;20(11):1491-1500. doi: 10.1080/14787210.2022.2122443. Epub 2022 Sep 12. Expert Rev Anti Infect Ther. 2022. PMID: 36069242
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
Montero MM, Domene-Ochoa S, López-Causapé C, López-Montesinos I, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Ferrer Alapont L, Grau S, Oliver A, Horcajada JP. Montero MM, et al. Among authors: lopez montesinos i, lopez causape c. Microbiol Spectr. 2022 Jun 29;10(3):e0089222. doi: 10.1128/spectrum.00892-22. Epub 2022 Jun 13. Microbiol Spectr. 2022. PMID: 35695526 Free PMC article.
36 results